Clinical Trials in Boston

Showing 8401-8420 of 17,836 trials

Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer

NCT02865811

This research study is studying the combination of Pegylated Liposomal Doxorubicin (PLD) and Pembrolizumab as a possible treatment for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer that is resistant to platinum therapy. The following interventions will be used in this study: * Pegylated liposomal doxorubicin (PLD) * Pembrolizumab

Ovarian CancerFallopian Tube CancerPeritoneal Cancer

Dana-Farber Cancer Institute26 participantsStarted Sep 2016

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Lake Success, New York, United States

COMPLETEDPhase 2< 1 mile

Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer

NCT03989362

JTX-2011-201 is a Phase 2, open label clinical study of vopratelimab (JTX-2011) and ipilimumab in adult subjects with non-small cell lung cancer (NSCLC) or urothelial cancer to evaluate safety and efficacy.

Cancer

Jounce Therapeutics, Inc.61 participantsStarted Jun 2019

Beverly Hills, California, United States • Los Angeles, California, United States • Newark, Delaware, United States +18 more locations

Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer

Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer

Find Trials by Condition in Boston

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Nivolumab+Ipilimumab+RT in MSS mCRC

Neural Correlates of Successful Cognitive Aging

Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Diagnosis of Alzheimer's Disease Using Event Related Potentials

Neuroeconomics of Social Behavior Following Trauma Exposure

Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Post Approval Study: NOVATION Ceramic Articulation Hip System

Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department

Platelet Rich Plasma (PRP) in Total Knee Replacement

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours